|
Name |
Tetratetracontane
|
Molecular Formula | C44H90 | |
IUPAC Name* |
tetratetracontane
|
|
SMILES |
CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
|
|
InChI |
InChI=1S/C44H90/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-43-44-42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h3-44H2,1-2H3
|
|
InChIKey |
KMXFZRSJMDYPPG-UHFFFAOYSA-N
|
|
Synonyms |
TETRATETRACONTANE; n-Tetratetracontane; 7098-22-8; FPX2NM4VIT; NSC-102262; Tetratetracontane, analytical standard; EINECS 230-407-0; NSC 102262; UNII-FPX2NM4VIT; Tetratetracontane, 99%; AI3-36493; DTXSID5058640; CHEBI:84289; ZINC6921186; MFCD00015268; NSC102262; AKOS015902653; AS-81740; Tetratetracontane, purum, >=95.0% (GC); FT-0753299; T72862; Q20890372; 1208B570-4CB6-48FD-9F3F-67129C995357; Tetratetracontane (C44) 1000 microg/mL in Carbon Disulfide
|
|
CAS | 7098-22-8 | |
PubChem CID | 23494 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 619.2 | ALogp: | 23.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 41 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 44 | QED Weighted: | 0.047 |
Caco-2 Permeability: | -5.91 | MDCK Permeability: | 0.00000024 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 1 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 111.00% |
Volume Distribution (VD): | 7.438 | Fu: | 0.24% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.073 |
CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.041 |
CYP2C9-inhibitor: | 0.001 | CYP2C9-substrate: | 0.992 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.002 |
CYP3A4-inhibitor: | 0.045 | CYP3A4-substrate: | 0.002 |
Clearance (CL): | 3.833 | Half-life (T1/2): | 0 |
hERG Blockers: | 0.566 | Human Hepatotoxicity (H-HT): | 0.001 |
Drug-inuced Liver Injury (DILI): | 0.602 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.003 | Maximum Recommended Daily Dose: | 0.091 |
Skin Sensitization: | 0.993 | Carcinogencity: | 0.005 |
Eye Corrosion: | 0.998 | Eye Irritation: | 0.919 |
Respiratory Toxicity: | 0.063 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000541 | 0.908 | D00AOJ | 0.459 | ||||
ENC001153 | 0.813 | D00STJ | 0.326 | ||||
ENC001204 | 0.793 | D01NTX | 0.322 | ||||
ENC000438 | 0.792 | D0Z1QC | 0.316 | ||||
ENC000576 | 0.769 | D06KDP | 0.314 | ||||
ENC000565 | 0.730 | D00FGR | 0.297 | ||||
ENC000381 | 0.723 | D07ILQ | 0.293 | ||||
ENC003062 | 0.701 | D0Z5SM | 0.260 | ||||
ENC000437 | 0.700 | D05ZPL | 0.253 | ||||
ENC001249 | 0.682 | D0T9TJ | 0.246 |